Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

1(20.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

5Total

Phase 2(2)

N/A(1)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05604131Phase 2Recruiting

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Role: collaborator

NCT07373678Completed

CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion

Role: collaborator

NCT05845580Not ApplicableCompleted

Patient Autonomy and Statin Therapy Adherence

Role: collaborator

NCT05253937Completed

Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .

Role: collaborator

NCT04552275Phase 1Recruiting

The HALT Biomarker Study

Role: collaborator

NCT01098591Completed

Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE

Role: collaborator

NCT00538759Phase 2Terminated

Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis

Role: collaborator

NCT02510547Phase 4Completed

Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial

Role: collaborator

All 8 trials loaded